26 Sep 2025 | 3 Mins Read
India Pharma Stocks Reel Following Trump Tariff Threat
Flipitmoney
Trump has announced a 100% tariff on imported branded or patented drugs effective October 1, unless companies are actively building U.S. manufacturing facilities. This puts Indian pharmaceutical exporters like Sun Pharma, Lupin, and Dr. Reddy’s in focus, as the U.S. is a major market for Indian generics and specialty drugs.